MannKind stock soared 7% as of Monday afternoon following news of a $925 million deal with Sanofi for its inhaled insulin drug Afrezza. More
For-Profit Colleges Have Little Blood Left to Give
Corinthian Colleges, ITT Educational Services, and other for-profit colleges look like a lost cause in their current state. More
Walmart vs. Target: Who Wins the CEO Shuffle? (WMT, TGT)
Reeling from disappointing earnings and myriad challenges, Target named former PepsiCo (PEP) executive Brian Cornell as its new CEO, while Walmart tapped Walmart Asia CEO Greg Foran to head up its critically important U.S. operations. Can either one deliver a turnaround? More
5 Best Sectors to Watch This Week
The commercial banking, aerospace and defense, life science, biotechnology and auto parts sectors are rising to the top this week on the Portfolio Grader database. More
Hedge Funds Sent Scrambling by Goldman Sachs
Only those hedge funds generating the highest profits will make the cut. Where will the other funds go for financing, and who will benefit? More
8 Capital Markets Stocks to Buy Now
Eight capital markets stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
